[go: up one dir, main page]

Chakraborty et al., 2018 - Google Patents

Protein-mediated shape control of silver nanoparticles

Chakraborty et al., 2018

Document ID
14525963050678133270
Author
Chakraborty I
Feliu N
Roy S
Dawson K
Parak W
Publication year
Publication venue
Bioconjugate chemistry

External Links

Snippet

Silver nanoparticles were grown in aqueous solution, without the presence of typical surfactant molecules, but under the presence of different proteins. The shape of the resulting silver nanoparticles could be tuned by the selection of the types of proteins. The amount of …
Continue reading at pubs.acs.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • A61K47/48876—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being a solid micro- or nanoparticle having no hollow or gas-filled core
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients

Similar Documents

Publication Publication Date Title
Chakraborty et al. Protein-mediated shape control of silver nanoparticles
Cao et al. DNA-modified core− shell Ag/Au nanoparticles
Charan et al. Development of chitosan oligosaccharide-modified gold nanorods for in vivo targeted delivery and noninvasive imaging by NIR irradiation
Crawford et al. Surface chemistry-mediated near-infrared emission of small coinage metal nanoparticles
Huang et al. Polyelectrolyte wrapping layers control rates of photothermal molecular release from gold nanorods
Xia et al. Quantifying the coverage density of poly (ethylene glycol) chains on the surface of gold nanostructures
Shang et al. Engineered nanoparticles interacting with cells: size matters
Kogan et al. Peptides and metallic nanoparticles for biomedical applications
Pelaz et al. Tailoring the synthesis and heating ability of gold nanoprisms for bioapplications
Dridi et al. Probing protein corona formation around gold nanoparticles: effects of surface coating
Yu et al. Polystyrene encapsulated SERS tags as promising standard tools: simple and universal in synthesis; highly sensitive and ultrastable for bioimaging
Ma et al. Monitoring of the enzymatic degradation of protein corona and evaluating the accompanying cytotoxicity of nanoparticles
Choi et al. Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells
Yin et al. Thermodynamics and mechanisms of the interactions between ultrasmall fluorescent gold nanoclusters and human serum albumin, γ-globulins, and transferrin: a spectroscopic approach
Qian et al. Highly efficient and controllable PEGylation of gold nanoparticles prepared by femtosecond laser ablation in water
Ren et al. One-step synthesis of water-soluble silver sulfide quantum dots and their application to bioimaging
Liu et al. A solution to the PEG dilemma: efficient bioconjugation of large gold nanoparticles for biodiagnostic applications using mixed layers
Centi et al. In vitro assessment of antibody-conjugated gold nanorods for systemic injections
Zou et al. Green synthesis of a gold nanoparticle–nanocluster composite nanostructures using trypsin as linking and reducing agents
Sethi et al. Linear assembly of Au nanorods using biomimetic ligands
Khlebtsov et al. Tip-functionalized Au@ Ag nanorods as ultrabright surface-enhanced Raman scattering probes for bioimaging in off-resonance mode
Cha et al. Effect of alkylamines on morphology control of silver nanoshells for highly enhanced Raman scattering
Sahraei et al. Formation of a highly stable and nontoxic protein corona upon interaction of human α-1-acid glycoprotein (AGP) with citrate-stabilized silver nanoparticles
Stover et al. Formation of small gold nanoparticle chains with high NIR extinction through bridging with calcium ions
Guo et al. Direct facile approach to the fabrication of Chitosan− Gold hybrid nanospheres